UAE Imposes Temporary Ban on Rice Exports and Re-Exports

A farmer harvests at a rice paddy on the outskirts of Srinagar, India. (AFP)
A farmer harvests at a rice paddy on the outskirts of Srinagar, India. (AFP)
TT

UAE Imposes Temporary Ban on Rice Exports and Re-Exports

A farmer harvests at a rice paddy on the outskirts of Srinagar, India. (AFP)
A farmer harvests at a rice paddy on the outskirts of Srinagar, India. (AFP)

The United Arab Emirates has temporarily banned rice exports and re-exports for four months as of Friday.

The decision included banning the export and re-export of rice originating India imported into the country, including free zones, after July 20.

The UAE Ministry of Economy said the ban would cover rice of all varieties including brown rice, fully or partially milled rice, and broken rice.

Companies wishing to export, or re-export rice must submit a request to the Ministry of Economy to obtain an export permit outside the country.

The permit would be issued “provided that the request is supported by all documents that help verify the data related to the shipment to be exported in terms of origin, the date of the transaction, and any other requirements that the ministry may require in this regard,” the statement added.

The ministry added that the permit to export rice products would be valid for 30 days and must be submitted to customs authorities, in order to complete procedures. Requests can be submitted online or directly at the headquarters of the Ministry of Economy.

The ministry said the decision can be extended automatically unless a decision is issued to cancel its implementation.

India had banned exports of non-basmati white rice in an effort to control rising prices and boost availability to Indian consumers.

From April to June this year, India’s exports of white rice except basmati rice rose by 35 percent.



UAE’s Mubadala Acquires Majority Stakes in Global Medical Supply Chain, Al Ittihad Drug

The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM
The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM
TT

UAE’s Mubadala Acquires Majority Stakes in Global Medical Supply Chain, Al Ittihad Drug

The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM
The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM

Mubadala Investment Company has acquired an 80% stake in Global Medical Supply Chain (GMSC) and Al Ittihad Drug Store (IDS) from GlobalOne Healthcare Holding (GHH), with GHH retaining a 20% stake, Emirates News Agency (WAM) reported on Tuesday.

This strategic acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors, aligning with the UAE's vision to establish a robust life sciences infrastructure, WAM said.

Founded in 2015, GMSC provides comprehensive end-to-end supply chain services for medical products, including demand planning, procurement, logistics, inventory management, warehousing, and maintenance.

GMSC serves over 200 medical facilities, including hospitals and clinics across the UAE. With a dedicated team of medical supply chain specialists, GMSC sources a broad array of products from almost 400 suppliers, ensuring a reliable supply chain for all medical needs.

IDS, established in 1987, stands as one of the leading distributors of pharmaceutical and consumer healthcare products in the UAE. Distributing over 1,000 products from over 40 leading suppliers, IDS services every hospital, and all, or at least most pharmacies and supermarkets within the UAE. It boasts a vast portfolio that spans multiple therapeutic categories including anti-infectives, asthma, diabetes, and oncology.

"The expanding pharmaceutical market drives an increasing demand for specialized and efficient drug logistics solutions. By integrating GMSC and IDS into our portfolio, we are poised to create a vertically integrated life sciences sector in the UAE and enable its potential to encompass the entire value chain from logistics and distribution to specialized manufacturing,” said Executive Director of UAE Clusters at Mubadala's UAE Investments Platform Ismail Ali Abdulla.

As for Low Ping, Group CEO Yas Holding, she said that the transaction “continues Mubadala's strategic growth, following another significant acquisition by its new speciality pharmaceutical business, KELIX bio, which recently acquired a 100% stake in four pharma assets from GlobalOne Healthcare Holding's, the healthcare division of Yas Holding.”

“These concerted efforts underline Mubadala's commitment to strengthening the UAE's healthcare and pharmaceutical sectors as part of broader national ambitions for drug security and economic diversification."

GlobalOne Healthcare Holding LLC serves as the dedicated Healthcare Division of Yas Holding LLC, focusing on enhancing healthcare outcomes by investing in innovative solutions across various healthcare verticals.